Worldwide Optometry Equipment Industry to 2030 - Featuring Canon, Carl Zeiss, Escalon Services and Essilor International Among Others

2022-09-10 14:18:22 By : Ms. Marita Wan

DUBLIN , Sept. 8, 2022 /PRNewswire/ -- The "Optometry Equipment Market, by Product Type, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to  ResearchAndMarkets.com's offering.

Optometry equipment are used to examine, diagnose, treat, and manage disease, injuries, disorders of the visual system, and associated structures. Moreover, it is used to identify systemic conditions affecting the eye. New technologies and diagnostic tools in optometric practice enhance the function of optometrist's clinical skills and optometry clinic instrumentation facilities.

Increasing incidence of eye diseases, availability of employer-sponsored vision care benefits, such as vision care insurance, discounted vision exams, glasses and contact lenses, increasing awareness regarding benefits of routine eye examination and reimbursement coverage for optometry services are expected to propel demand for advanced optometry equipment during the forecast period. Market Dynamics

Increasing incidence of various eye disease and new technology advancements in optometry equipment, which helps to expand the scope and efficiency in vision care practices are expected to fuel growth of the optometry equipment market. Moreover, the initiatives taken by the government to control the visual impairment is another major factor imposing a positive outlook on the market growth.

A key factor in the prevalence of blindness is the inadequate availability of primary eye care, compounded by a lack of awareness and poor access to quality eye care products. In addition, increasing healthcare spending and technological advancements are other factors contributing to the market growth New diagnostic tools in the field of optometry equipment market such as digital fundus camera, optimal coherence tomography, advanced retinal camera, tonometer, specular microscope, ultra wide field internal imaging camera, slit camera, visual field tester, automated refractor, and advanced phoropter are improving the diagnostic ability of an optometrist. Key features of the study:

This report provides an in-depth analysis of the global optometry equipment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global optometry equipment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Canon Inc., Carl Zeiss AG, Escalon Services, Inc., Essilor International S.A., Haag-Streit AG, Heidelberg Engineering GmbH, Heine Optotechnik GmbH & Co. KG, Luneau Technology Group, NIDEK CO., LTD., Novartis International AG, and Topcon Corporation.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global optometry equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global optometry equipment market

Key Topics Covered: 1. Research Objectives and Assumptions

Market Snapshot, By Product Type

Market Snapshot, By End User

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Optometry Equipment Market- Impact of Coronavirus (Covid-19) Pandemic

Impact on Supply and Demand

COVID-19 Impact on the market

5. Global Optometry Equipment Market, By Product Type, 2017 - 2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Optometry Equipment Market, By End User, 2017 - 2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Optometry Equipment Market, By Region, 2017 - 2030, (US$ Million)

Heine Optotechnik GmbH & Co. KG

For more information about this report visit https://www.researchandmarkets.com/r/y4wrgp

Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/worldwide-optometry-equipment-industry-to-2030---featuring-canon-carl-zeiss-escalon-services-and-essilor-international-among-others-301620135.html

Various CVS, Rite Aid and Walgreens pharmacy locations in the Coachella Valley have appointment slots available for booster shots.

As we close in on the final quarter of 2022, investors are looking for an answer to one question: was June’s low the bottom for stocks, or do they have more room to fall? It’s a serious question, and there may be no easy answer. Markets are facing a series of headwinds, from the high inflation and rising interest rates that we’ve grown familiar with to an increasingly strong dollar that will put pressure on the upcoming Q3 earnings. Weighing in on current conditions from Charles Schwab, the $8 t

The S&P 500 is on again, off again all year. But investors clearly have a "buy list" of stocks they want to own when the rally looks real.

During tricky market conditions, it can be helpful to follow professional investors who are focused on the long term.

It's time to be extra picky.

Tough times ahead. But you don't need to sell it all.

The automaker's resilience in this economic downturn is something to be admired

Congressional Democrats want to slam shut a tax loophole known as the "backdoor" Roth IRA. In one of several proposed changes that target the retirement accounts of wealthy Americans, Democrats on the House Ways and Means Committee want to prohibit people … Continue reading → The post Democrats Want to End This Lucrative Retirement Account Loophole appeared first on SmartAsset Blog.

In this article, we will look at 10 stocks that Jim Cramer is talking about in September. If you want to explore more stocks that journalist investor, Jim Cramer, is talking about in September, you can also take a look at Jim Cramer is Talking About These 5 Stocks in September. Jim Cramer has acquired […]

A strong bearish trend defined the markets in the first half of the year; since then, the key point has been volatility. Stocks hit a bottom back in June, when the S&P 500 dropped into the 3,600s. That has proven to be a support level in the last two months, and at least one strategist believes that the market won’t be testing those lows again this year. JPMorgan's Jason Hunter believes that inflation may have peaked, and that the upcoming CPI report will provide additional evidence of that. “We

BullsEyeOption.com Chief Market Strategist Alan Knuckman joins Yahoo Finance Live to discuss energy markets and how Europe's energy crisis could impact both the U.S. and China.

The old saying “different strokes for different folks” certainly rings true in the stock market. Some investors prefer growth stocks like Tesla Inc. that are volatile but have produced years of outstanding appreciation. Other folks prefer less volatile stocks like Johnson & Johnson whose growth may be slower but also add dividends of 2% to 3% annually to the total performance. In addition, there are income investors, who strictly look for stocks that will provide high-yield dividends year after

(Bloomberg) -- In a week that saw discretionary buyers beat a quick retreat from risky assets, another set of traders stood up to halt a three-week plunge in the S&P 500: those with little choice but to buy.Most Read from BloombergCharles Becomes King as the Face of a Nation ChangesDouble Rainbow Appears Over Buckingham Palace as Crowd Gathers to Mourn QueenUkraine Army’s Breakthrough in North Threatens Russian GripQueen Elizabeth’s Doctors Are Concerned for Her HealthQueen Elizabeth II, Britain

Warren Buffett's Berkshire Hathaway disclosed its Occidental Petroleum stake has risen to 26.8%. OXY stock rose slightly late Friday.

These stocks have what it takes to provide shareholders solid returns if they take a long-term view on investing.

Investors are seeing higher growth potential for QuantumScape's battery cell technology after an interesting EV industry development.

AT&T income-hungry shareholders should have seen it coming. In April last year, a month before announcing the spinoff of its media division to shareholders in the form of shares of a 71% stake in the newly created Warner Bros. Discovery Chief Executive Officer John Stankey assured investors that “our deliberate capital-allocation plan allowed us to invest and sustain our dividend at current levels, which we believe is attractive.” AT&T’s eventual failure to raise the dividend in 2021 broke a 34-year streak and saw it booted out of the vaunted S&P 500 Dividend Aristocrats Index.

To complicate matters, these bearish conditions are occurring at the same time as general turmoil in the cannabis industry wrought by an oversupply of marijuana products and numerous companies struggling to become or remain profitable. After falling by more than 73% in the last 12 months, the market does not seem to be optimistic over Tilray Brands (NASDAQ: TLRY) stock. What's more, it could soon get its chance to more fully exploit the cannabis market in the E.U. This summer, several European countries, including Germany, Malta, and Luxembourg, made early political moves to pave the way for recreational cannabis legalization.

On Friday, the company unveiled the Robinhood Investor Index, which captures how customers invest based on the top 100 most owned stocks on the platform.

Verizon Communications Inc.'s ( NYSE:VZ ) periodic dividend will be increasing on the 1st of November to $0.6525, with...